Helicobacter pylori and gastric cancer

Current Opinion in Gastroenterology

Volumn 22, Issue 6, 2006, Pages 620-625

  Pritchard, D Mark ^a   Crabtree, Jean E ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

cag pathogenicity island; Gastric cancer; Gastritis; Helicobacter pylori; Stem cells

Indexed keywords

BACTERIAL VACCINE; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ETODOLAC; NIMESULIDE;

APOPTOSIS; ATROPHIC GASTRITIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COHORT ANALYSIS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; GENETIC POLYMORPHISM; HELICOBACTER FELIS; HELICOBACTER PYLORI; HELMINTHIASIS; HEMATOPOIETIC STEM CELL; HEREDITY; HUMAN; MEDICAL RESEARCH; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; PATHOGENICITY; PROGNOSIS; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOMA; TH1 CELL;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 33750312773     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000245539.50765.f6     Document Type: Review

References (72)

1. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005; 128:1567-1578.
2. Peek RM Jr, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006; 208:233-248.
3. Crabtree JE, Naumann M. Epithelial cell signalling in Helicobacter pylori infection. Curr Signal Transduction Ther 2006; 1:53-65.
4. Pritchard DM, Przemeck SM. How useful are the rodent animal models of gastric adenocarcinoma? Aliment Pharmacol Ther 2004; 19:841-859.
5. Nozaki K, Tanaka H, Ikehara Y, et al. Helicobacter pylori-dependent NF-kappa B activation in newly established Mongolian gerbil gastric cancer cell lines. Cancer Sci 2005; 96:170-175.
6. Rieder G, Merchant JL, Haas R. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 2005; 128:1229-1242. In-vivo evidence in the Mongolian gerbil of the importance of the cag PAI in promoting severe gastric pathology.
7. Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 2005; 96:835-843.
8. Zhu Y, Zhong X, Zheng S, et al. Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway. Oncogene 2005; 24:3886-3895.
9. Suzuki M, Mimuro H, Suzuki T, et al. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med 2005; 202:1235-1247. Evidence that phosphorylated CagA binds cytoplasmic Crk adaptor proteins and disrupts E-cadherin/catenin containing adherens junctions in epithelial cells.
10. Franco AT, Israel DA, Washington MK, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 2005; 102:10646-10651. Epithelial translocated CagA activates β-catenin in gastric epithelial cell lines and an in-vivo adapted H. pylori strain, which selectively activates β-catenin, induces dysplasia and adenocarcinoma in the Mongolian gerbil model.
11. Bagnoli F, Buti L, Tompkins L, et al. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A 2005; 102:16339-16344. Further evidence that CagA disrupts epithelial apical junctions and alters differentiation of polarised epithelial cells.
12. Conlin VS, Curtis SB, Zhao Y, et al. Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect Immun 2004; 72:5181-5192.
13. Yamaoka Y, Ojo O, Fujimoto S, et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006; 55:775-781.
14. Carlsohn E, Nystrom J, Bolin I, et al. HpaA is essential for Helicobacter pylori colonization in mice. Infect Immun 2006; 74:920-926.
15. Unemo M, Spholm-Hurtig M, Ilver D, et al. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J Biol Chem 2005; 280:15390-15397. A study identifying the adhesin SabA as the inducer of nonopsonic neutrophil activation.
16. O'Brien DP, Israel DA, Krishna U, et al. The role of decay-accelerating factor as a receptor for Helicobacter pylori and a mediator of gastric inflammation. J Biol Chem 2006; 281:13317-13323. Identification of epithelial DAF, a regulator of complement mediated lysis, as a receptor for H. pylori.
17. Mandell L, Moran AP, Cocchiarella A, et al. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 2004; 72:6446-6454.
18. Lepper PM, Triantafilou M, Schumann C, et al. Lipopolysaccharides from Helicobacter pylori can act as antagonists for toll-like receptor 4. Cell Microbiol 2005; 7:519-528.
19. Backhed F, Rokbi B, Torstensson E, et al. Gastric mucosal recognition of Helicobacter pylori is independent of toll-like receptor 4. J Infect Dis 2003; 187:829-836.
20. Yamaoka Y, Yamauchi K, Ota H, et al. Natural history of gastric mucosal cytokine expression in Helicobacter pylori gastritis in Mongolian gerbils. Infect Immun 2005; 73:2205-2212.
21. Crabtree JE, Court M, Aboshkiwa MA, et al. Gastric mucosal cytokine and epithelial cell responses to Helicobacter pylori infection in Mongolian gerbils. J Pathol 2004; 202:197-207.
22. Kang W, Rathinavelu S, Samuelson LC, Merchant JL. Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab Invest 2005; 85: 702-715.
23. Tu SP, Cui GL, Takaishi S, et al. Overexpression of human interleukin-1beta in transgenic mice results in spontaneous gastric inflammation and carcinogenesis [abstract]. Gastroenterology 2005; 128:A62.
24. Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004; 23:1669-1678.
25. Oshima M, Oshima H, Matsunaga A, Taketo MM. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res 2005; 65:9147-9151. Identification that TNF-α-dependent inflammation is responsible for gastric hyperplasia and expansion of the preneoplastic SPEM lineage of cells in transgenic mice expressing cyclooxygenase-2 and microsomal prostaglandin E synthase-1.
26. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
27. Zabaleta J, Camargo MC, Piazuelo MB, et al. Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol 2006; 101:163-171.
28. Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005; 114:237-241.
29. Togawa S, Joh T, Itoh M, et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005; 10:172-178.
30. Lobo GL, Zambaldi TM, de Labio RW, et al. Interleukin-6 polymorphism and Helicobacter pylori infection in Brazilian adult patients with chronic gastritis. Clin Exp Med 2005; 5:112-116.
31. Ohyauchi M, Imatani A, Yonechi M, et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005; 54:330-335.
32. Lu W, Pan K, Zhang L, et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26:631-636.
33. Navaglia F, Basso D, Zambon CF, et al. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals. J Med Genet 2005; 42:503-510.
34. Goto Y, Ando T, Yamamoto K, et al. Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer 2006; 118:203-208. The G/A SNP in PTPN11 was identified as a risk factor for atrophy in cagA-positive H. pylori infections in a Japanese cohort.
35. Martin JH, Potthoff A, Ledig S, et al. Effect of H pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis. Helicobacter 2004; 9:371-386.
36. Cai X, Stoicov C, Li H, et al. Overcoming Fas-mediated apoptosis accelerates Helicobacter-induced gastric cancer in mice. Cancer Res 2005; 65:10912-10920.
37. Eguchi H, Carpentier S, Kim SS, Moss SF. P27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori. Gut 2004; 53:797-804.
38. kip1 deficient mice were shown to develop gastric cancer with H. pylori infection.
39. Kim SS, Meitner P, Konkin TA, et al. Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H pylori eradication in chronic gastritis. Mod Pathol 2006; 19:49-58.
40. Yoshino N, Ishihara S, Rumi MA, et al. Interleukin-8 regulates expression of Reg protein in Helicobacter pylori-infected gastric mucosa. Am J Gastroenterol 2005; 100:2157-2166.
41. Mutoh H, Sakurai S, Satoh K, et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004; 53:1416-1423.
42. Rieder G, Tessier AJ, Qiao XT, et al. Helicobacter-induced intestinal metaplasia in the stomach correlates with Elk-1 and serum response factor induction of villin. J Biol Chem 2005; 280:4906-4912.
43. Manzo BA, Crabtree JE, Fiona CM, et al. Helicobacter pylori regulates the expression of inhibitors of DNA binding (Id) proteins by gastric epithelial cells. Microbes Infect 2006; 8:1064-1074.
44. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118:36-47.
45. Fox JG, Rogers AB, Ihrig M, et al. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003; 63:942-950.
46. Takaishi S, Cui G, Frederick DM, et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 2005; 128:1965-1983. The development of gastric atrophy and cancer in H. felis infected INS-GAS mice were inhibited by gastrin/CCK-2 and histamine H2-receptor antagonists.
47. Cui G, Koh TJ, Chen D, et al. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res 2004; 64:8160-8166.
48. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306:1568-1571.
49. Oh JD, Karam SM, Gordon JI. Intracellular Helicobacter pylori in gastric epithelial progenitors. Proc Natl Acad Sci U S A 2005; 102:5186-5191.
50. Oh JD, Kling-Backhed H, Giannakis M, et al. Interactions between gastric epithelial stem cells and Helicobacter pylori in the setting of chronic atrophic gastritis. Curr Opin Microbiol 2006; 9:21-27.
51. Iwamoto J, Mizokami Y, Takahashi K, et al. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Scand J Gastroenterol 2005; 40:783-793.
52. Kim MH, Yoo HS, Chang HJ, et al. Urokinase plasminogen activator receptor is upregulated by Helicobacter pylori in human gastric cancer AGS cells via ERK, JNK, and AP-1. Biochem Biophys Res Commun 2005; 333:874-880.
53. Beyer BC, Heiss MM, Simon EH, et al. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens. Cancer 2006; 106:1026-1035.
54. Wroblewski LE, Noble PJ, Pagliocca A, et al. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration. J Cell Sci 2003; 116:3017-3026.
55. Krueger S, Hundertmark T, Kalinski T, et al. Helicobacter pylori encoding the pathogenicity island activates matrix metalloproteinase 1 in gastric epithelial cells via JNK and ERK. J Biol Chem 2006; 281:2868-2875.
56. Hemers E, Duval C, McCaig C, et al. Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling. Cancer Res 2005; 65:7363-7369.
57. McCaig C, Duval C, Hemers E, et al. The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. Gastroenterology 2006; 130:1754-1763. Epithelial derived matrix metalloproteinase-7 was shown to increase IGF-II release from mesenchymal myofibroblasts, which in turn promoted epithelial cell and myofibroblast proliferation.
58. Rogers AB, Taylor NS, Whary MT, et al. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res 2005; 65:10709-10715.
59. Shikata K, Kiyohara Y, Kubo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006; 119:196-201.
60. Agha A, Graham DY. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol 2005; 40:523-529. A critical evaluation of the evidence for reduced levels of gastric cancer in Africa.
61. Du Y, Agnew A, Ye XP, et al. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H pylori and serum pepsinogen I/II ratio. Microbes Infect 2006; 8:52-60. Helminth coinfection in a Chinese population reduced the probability of low serum pepsinogen I/pepsinogen II ratio, a marker of corpus atrophy, with H. pylori infection.
62. Whary MT, Sundina N, Bravo LE, et al. Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev 2005; 14:1464-1469.
63. Jeremy AH, Du Y, Dixon MF, et al. Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination. Microbes Infect 2006; 8:340-346.
64. Cai X, Carlson J, Stoicov C, et al. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 2005; 128:1937-1952. Demonstration of stage at which H. felis eradication prevents gastric carcinoma development in a widely employed mouse model
65. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12:989-995.
66. Chan AO, Peng JZ, Lam SK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006; 55:463-468. Evidence that eradication of H. pylori reverses promoter methylation of E-cadherin in the gastric mucosa.
67. Tsai CJ, Herrera-Goepfert R, Tibshirani RJ, et al. Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy. Cancer Epidemiol Biomarkers Prev 2006; 15:272-280.
68. Sun YQ, Girgensone I, Leanderson P, et al. Effects of antioxidant vitamin supplements on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2005; 10:33-42.
69. Magari H, Shimizu Y, Inada K, et al. Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils. Biochem Biophys Res Commun 2005; 334: 606-612.
70. Nam KT, Hahm KB, Oh SY, et al. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res 2004; 10:8105-8113.
71. Li GQ, Xia HH, Chen MH, et al. Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation. J Infect Dis 2006; 193:1037-1046.
72. Meimarakis G, Winter H, Assmann I, et al. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 2006; 7:211-222. Human study demonstrating poorer prognosis in a large cohort of H. pylori negative patients with gastric cancer undergoing potentially curative surgical resection.